Home>Latest
- September 13, 2024
Intl agency chief lauds China's IP protection
China's enhanced awareness of intellectual property protection as well as its innovation output in science and technology over the past few years has been praised by Daren Tang, director general of the World Intellectual Property Organization.
- September 13, 2024
China's big role in global green transition
Over the past decade, China has made remarkable contributions to global green transformation, thanks to its continuous technological advancements, complete industrial supply chains and favorable market environment, according to a recently released white paper.
- September 13, 2024
Open markets to lure foreign firms
Reduced entry barriers to foster more enabling landscape for overseas and domestic entities
- September 13, 2024
Slovakia welcomes Ningbo investors with open arms
In an enthusiastic and fluent Chinese address, Slovakia's representative Michal Dutko warmly welcomed Ningbo entrepreneurs to explore investment opportunities in his country during an economic exchange event in Ningbo, Zhejiang province, on Sept 12.
- September 13, 2024
Ningbo's foreign trade volume hits 934.49b yuan in Jan-Aug
Ningbo's total imports and exports hit 934.49 billion yuan ($131.79 billion) in the first eight months of this year, marking a 10.9 percent increase compared to the corresponding period last year, according to data recently released by Ningbo Customs.
- September 12, 2024
Open markets to lure foreign firms
Reduced entry barriers to foster more enabling landscape for overseas and domestic entities
- September 12, 2024
International students embrace Chinese Mid-Autumn traditions
A special event brought together international students at Ningbo University from Morocco, Yemen, and beyond to celebrate the upcoming Mid-Autumn Festival, which falls on Sept 17 this year, through cultural immersion on Sept 11.
- September 12, 2024
Chinese mpox vaccine to undergo clinical trial
The country's top drug regulator has cleared a mpox vaccine developed by Chinese drugmaker Sinopharm for clinical trial on Monday, which could be the nation's first experimental dose to battle the deadly disease, according to the company.
